Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo

被引:36
|
作者
Yao, Dahong [1 ]
Pan, Dabo [5 ,6 ]
Zhen, Yongqi [2 ,3 ,4 ]
Huang, Jian [7 ]
Wang, Jinhui [7 ,8 ]
Zhang, Jin [2 ,3 ,4 ]
He, Zhendan [1 ]
机构
[1] Shenzhen Univ, Guangdong Key Lab Genome Stabil & Human Dis Preve, Sch Pharmaceut Sci,Shenzhen Key Lab Novel Nat Hlt, Innovat Platform Nat Small Mol Drugs,Engn Lab She, Shenzhen 518060, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China
[4] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
[5] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Peoples R China
[6] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Peoples R China
[7] Shenzhen Honghui Biopharmaceut Co Ltd, Shenzhen 518118, Peoples R China
[8] Harbin Med Univ, Coll Pharm, Harbin 150081, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Ferulin C; Tubulin polymerization; Breast cancer; Apoptosis; Autophagy; Metastasis; DERIVATIVES; TARGET; MICROTUBULES; SUPPRESSES; AUTOPHAGY; MIGRATION; DATABASE; CELLS; RAF;
D O I
10.1016/j.phrs.2019.104605
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ferulin C, a natural sesquiterpene coumarin, isolated from the roots of Ferula ferulaeoides (Steud.) Korov, displaying potent antiproliferatory activity against breast cancer cells. This study aimed to elucidate the underlying molecular mechanisms of Ferulin C-induced breast cancer cells death in vitro and in vivo. Ferulin C presented potent antiproliferatory activity against MCF-7 and MDA-MB-231 cells and remarkable tubulin polymerization inhibitory activity (IC50 = 9.2 mu M). Meanwhile, we predicted Ferulin C bind to the Colchicine site of tubulin through CETSA assay, molecular docking and molecular dynamics (MD) simulations. In immunofluorescence assay, Ferulin C disturbed the microtubule integrity and structure. Furthermore, Ferulin C stimulated significant cell cycle arrest in the G1/S period via p21(ClP1/Waf1)- CDK2 signaling, induced classic cell apoptosis, impaired metastasis via down-regulating Ras-Raf-ERK and AKT-mTOR signaling. Intriguingly, Ferulin C treatment induced autophagy by ULK1 signaling to synergize with the inhibition of proliferation and metastasis. Based upon the RNAseq analysis, PAK1, as a novel essential modulator, was involved in the signaling regulated by Ferulin C-induced alpha/beta-tubulin depolymerization. Additionally, Ferulin C displayed an acceptable antiproliferatory activity in an MCF-7 xenograft model without inducing obvious weight loss in the Ferulin C treated mice that Ferulin G was a potent, colchicine sites binding microtubule destabilizing agent with anti-proliferation and anti-metastasis activity via PAK1 and p21-mediated signaling in breast cancer cells.
引用
收藏
页数:14
相关论文
共 39 条
  • [31] C6 Ceramide Potentiates Paclitaxel and Gemcitabine-mediated Anti-tumor Effects against Pancreatic Cancer in vivo and in vitro via Inhibition of Pro-survival PI3k/AKT/mTOR and ERK/MAPK Pathways
    Wanebo, H.
    Lu, S.
    Cao, C.
    Shrayer, D.
    Bowen, W.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S165 - S165
  • [32] Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo
    Hasanpourghadi, Mohadeseh
    Pandurangan, Ashok Kumar
    Karthikeyan, Chandrabose
    Trivedi, Piyush
    Mustafa, Mohd Rais
    ONCOTARGET, 2017, 8 (17) : 28840 - 28853
  • [33] Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice
    Varshosaz, Jaleh
    Enteshari, Saeede
    Hassanzadeh, Farshid
    Hashemi-Beni, Batool
    Minaiyan, Mohsen
    Mirsafaei, Razieh
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (07) : 1139 - 1157
  • [34] Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling
    Li, Ning
    Sun, Ya-Jie
    Huang, Li-Yun
    Li, Rong-Rong
    Zhang, Jun-Sheng
    Qiu, Ai-Hua
    Wang, Jing
    Yang, Lu
    DRUG RESISTANCE UPDATES, 2025, 78
  • [35] Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling
    Brandhorst, Sebastian
    Longo, Valter D.
    DRUG RESISTANCE UPDATES, 2025, 78
  • [36] p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo
    Liu, Manran
    Casimiro, Mathew C.
    Wang, Chenguang
    Shirley, L. Andrew
    Jiao, Xuanmao
    Katiyar, Sanjay
    Ju, Xiaoming
    Li, Zhiping
    Yu, Zuoren
    Zhou, Jie
    Johnson, Michael
    Fortina, Paolo
    Hyslop, Terry
    Windle, Jolene J.
    Pestell, Richard G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (45) : 19035 - 19039
  • [37] Metformin Affects the Proliferation Cell Nuclear Antigen (PCNA) and p21 Protein Interaction Resulting in Direct Anti-Tumor Activity and Enhances the Cytotoxic/Biological Effects of Chemotherapy Agents or Rituximab in Lymphoma in Vitro and in Vivo Pre-Clinical Models
    Gu, Juan J.
    Yanamadala, Vivek
    Singh, Anil
    Mavis, Cory
    Czuczman, Myron S.
    Hernandez, Francisco
    BLOOD, 2014, 124 (21)
  • [38] BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-proliferative Activity in P-gp170 (MDR1)-mediated VX680-resistant Cancer Cells in Vitro and in Vivo
    Hsieh, H. P.
    Cheung, C. H. A.
    Lin, W. H.
    Hsu, T. A.
    Coumar, M. S.
    Chao, Y. S.
    Chang, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S127 - S127
  • [39] Combination Therapy of the Novel PI3K Inhibitor GDC-0941 and Dual PI3K/mTOR Inhibitor GDC-0980 with Trastuzumab-DM1 Antibody Drug Conjugate Enhances Anti-Tumor Activity in Preclinical Breast Cancer Models In Vitro and In Vivo
    Sampath, D.
    Fields, C.
    Li, G.
    Prior, W. W.
    Parsons, K.
    Friedman, L. S.
    Lewis-Phillips, G. D.
    CANCER RESEARCH, 2010, 70